7.9(top 1%)
Impact Factor
8.5(top 1%)
extended IF
116(top 3%)
citing journals
citing authors

Most Cited Articles of Liver International

The global burden of hepatitis C20091K
Role of Kupffer cells in host defense and liver disease2006568
Diagnosis and phenotypic classification of Wilson disease2003556
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study2015505
Liver injury during highly pathogenic human coronavirus infections2020504
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt2011412
Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B2009369
The epidemiology of non-alcoholic fatty liver disease2017367
Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus2009353
Hepatitis C virus infection in USA: an estimate of true prevalence2011323
Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity2012315
Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis2013300
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel2011293
Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis2011281
Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment2008273
Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China2020271
Hepatitis E and pregnancy: understanding the pathogenesis2008268
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update2005261
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients2010254
Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies2009234
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography2012233
Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis2012231
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography2012222
Experimental models of hepatic encephalopathy: ISHEN guidelines2009219
Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function2016217